← All organizations

Bateman Horne Center

Academic/Hospital

Also known as: Bateman Horne Center | LUCINDA BATEMAN, MD

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Oct 15, 2023

Timeline

No events for the selected filters.

Drugs by trial phase (7 distinct, 6 trials)

Phase 3 (1 own, 0 via acquisition)

rintatolimod

Phase 2 (3 own, 0 via acquisition)

Other trials (3 own, 0 via acquisition)

Indications

Studied for

Recent trials (14)

NCT06316843OfficialPhase 2Oct 15, 2023
NCT06316843Sponsor investigatorPhase 2Oct 15, 2023
NCT06316843Lead sponsorPhase 2Oct 15, 2023
NCT05840237CollaboratorN/AJun 1, 2023
NCT05840237Overall official - principal investigatorN/AJun 1, 2023
NCT05467904Lead sponsorN/AOct 31, 2022
NCT05467904Sponsor investigatorN/AOct 31, 2022
NCT05273372CollaboratorN/AMar 15, 2022
NCT05273372Overall official - principal investigatorN/AMar 15, 2022
NCT03613129Study directorPhase 1/Phase 2Jul 23, 2018
NCT03613129Lead sponsorPhase 1/Phase 2Jul 23, 2018
NCT03613129Sponsor investigatorPhase 1/Phase 2Jul 23, 2018
NCT03613129Overall official - principal investigatorPhase 1/Phase 2Jul 23, 2018
NCT00215813Overall official - principal investigatorPhase 3Mar 1, 1997

Details

Last known activity: Oct 15, 2023